“There is a painful awareness among communities in countries whose economies are growing that donors are pulling out and abandoning them… This [transitioning] process is driven by the criteria donors have laid out for eligibility, and demonstrated by the actual level of disbursements going to some countries. But communities know that growing economies do not equal growing domestic support for communities in the HIV response.”
The Global Fund, one of the main purchasers of generic antiretroviral (ARV) medicines for HIV patients in low- and middle-income countries, has dismissed concerns that the limited number of manufacturers tapped to supply these drugs could result in immediate or future shortages. Fund officials said systems are in place to forecast demand, deal with any supply disruptions and increase production to meet future need.
After initially rejecting a plea for assistance from Venezuelan NGOs out of hand, the Global Fund now says it may be able to help
In an exchange of letters that spanned more than seven months, the Global Fund at first rejected a plea for help from the Venezuelan Network of Positive People (RVG+), but then may have left the door open to providing some assistance via other agencies. This is a story that is still unfolding.
According to the Global Fund, Venezuela is currently not eligible for funding under the Fund’s Eligibility Policy.
The Global Fund has pledged to re-energize HIV prevention and, in line with that commitment, civil society groups are calling on the Fund to offer more explicit data on how much it spends on these efforts. That includes not only overall expenditure data, but also granular information, like spending at a country level and spending on specific interventions.
AHF and researchers call for more transparency in UNAIDS’ estimates of the numbers of people on ARVs
The AIDS Healthcare Foundation (AHF), a Los Angeles-based AIDS service and activist organization with a global reach, has called for more transparency and accountability in the way UNAIDS estimates the number of people living with HIV/AIDS who are on life-saving antiretroviral treatment.
At Financing for Development conference, the outlines of a plan to fund the post-2015 development agenda
A high-level meeting of global stakeholders took place 13-16 July in Addis Ababa to develop a strategy to finance the post-2015 sustainable development goals, against a backdrop of donor fatigue, the enduring global financial crisis and a growing insistence on improved domestic financing for development issues.
Despite continued concerns about Malawi’s ability to absorb grant funds, the country will receive an additional $37 million in incentive funding to support its HIV program, bringing the total allocation under the new funding model for this central African nation for all three diseases and health systems strengthening to more than $611 million.
A UNAIDS special report released in November has warned of a risk that regional progress in Asia and the Pacific in stemming the spread of HIV is stagnating, recommending a closer look at value for money and strategic targets for external and domestic co-financing of prevention, treatment and care activities.
The law passed the Nigerian national assembly in May 2013 but President Goodluck Jonathan resisted signing it until early January, doing so with little fanfare as he knew the likely firestorm it would provoke among Nigeria’s development partners.